Organisation paid for research Program year 2023 Source: CMS Open Payments

Medisync Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$261,546

398 payments

Through program year 2023, Medisync Clinical Research, LLC is reported as receiving $261,546 in research payments, across 398 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $39,722 13
2022 Research $12,099 7
2021 Research $32,141 158
2020 Research $62,031 197
2019 Research $115,552 23

Breakdown

Who paid Research payments · program years 2019–2023
  1. AbbVie, Inc. $114,032 13 payments
  2. Novo Nordisk AS $109,792 373 payments
  3. Swing Therapeutics, Inc. $37,722 12 payments
Studies the money was for Research payments · program years 2019–2023
  1. M16-100 $114,032 13 payments
  2. Nn9536-4451 $78,432 244 payments
  3. PROSPER-FM": Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management $37,722 12 payments
  4. Nn8022-4180 $23,889 4 payments
  5. Nn8022-4392 $7,471 125 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record